Production of a type 2 maternal diabetes rodent model using the combination of high-fat diet and moderate dose of streptozocin

Endocrine Research

Volumn 35, Issue 2, 2010, Pages 59-70

  Gutierrez, J Claudio ^a,b   Bahamonde, Javiera ^a,b   Prater, M Renee ^b,c   Yefi, Claudia P ^a   Holladay, Steven D ^d  

^a UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^c EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^d UNIVERSITY OF GEORGIA   (United States)

Author keywords

Diabetes and Pregnancy; Mouse Models of Diabetes; Type 1 Diabetes; Type 2 Diabetes

Indexed keywords

INSULIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEMALE; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LIPID DIET; MATERNAL DIABETES MELLITUS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; DIETARY FATS; DISEASE MODELS, ANIMAL; FEMALE; INSULIN; MICE; PREGNANCY; PREGNANCY IN DIABETICS; STREPTOZOCIN;

EID: 77951686524     PISSN: 07435800     EISSN: 15324206     Source Type: Journal    
DOI: 10.3109/07435801003641939     Document Type: Article

References (25)

1. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006; 29(Suppl. 1):S43-S48.
2. Hillier TA, Vesco KK, Pedula KL, Beil TL, Whitlock EP, Pettitt DJ. Screening for gestational diabetes mellitus: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2008; 148:766-775.
3. Devedjian JC, George M, Casellas A, et al. Transgenic mice overexpressing insulin-like growth fac-tor-II in beta cells develop type 2 diabetes. J Clin Invest 2000; 105:731-740.
4. Like AA, Rossini AA. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 1976; 193:415-417.
5. Goldman AS, Baker L, Piddington R, Marx B, Herold R, Egler J. Hyperglycemia-induced teratoge-nesis is mediated by a functional deficiency of arachidonic acid. Proc Natl Acad Sci USA 1985; 82:8227-8231.
6. Punareewattana K, Holladay SD. Immunostimulation by complete Freund's adjuvant, granulocyte macrophage colony-stimulating factor, or interferon-gamma reduces severity of diabetic embryop-athy in ICR mice. Birth Defects Res A Clin Mol Teratol 2004; 70:20-27.
7. Luo J, Quan J, Tsai J, et al. Nongenetic mouse models of non-insulin-dependent diabetes mellitus. Metabolism 1998; 47:663-668.
8. Mu J, Woods J, Zhou YP, et al. Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes. Diabetes 2006; 55:1695-1704.
9. Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 148:759-765.
10. Yamashita H, Shao J, Friedman JE. Physiologic and molecular alterations in carbohydrate metabolism during pregnancy and gestational diabetes mellitus. Clin Obstet Gynecol 2000; 43:87-98.
11. Eroglu D, Zeyneloglu HB. Metabolic disorders in patients with recent gestational diabetes mellitus. J Obstet Gynaecol Res 2006; 32:408-415.
12. Shao J, Catalano PM, Yamashita H, et al. Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes mellitus (GDM): evidence for increased serine/threonine phosphorylation in pregnancy and GDM. Diabetes 2000; 49:603-610.
13. Hrubec TC, Prater MR, Toops KA, Holladay SD. Reduction in diabetes-induced craniofacial defects by maternal immune stimulation. Birth Defects Res B Dev Reprod Toxicol 2006; 77:1-9.
14. Gutierrez JC, Hrubec TC, Prater MR, Smith BJ, Freeman LE, Holladay SD. Aortic and ventricular dilation and myocardial reduction in gestation day 17 ICR mouse fetuses of diabetic mothers. Birth Defects Res A Clin Mol Teratol 2007; 79:459-464.
15. Park SH, Ko SK, Choi JG, Chung SH. Salicornia herbacea prevents high fat diet-induced hypergly-cemia and hyperlipidemia in ICR mice. Arch Pharm Res 2006; 29:256-264.
16. Reed MJ, Meszaros K, Entes LJ, et al. A new rat model of type 2 diabetes: the fat-fed, streptozoto-cin-treated rat. Metabolism 2000; 49:1390-1394.
17. Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 2005; 52:313-320.
18. Lenzen S. The mechanisms of alloxan-and streptozotocin-induced diabetes. Diabetologia 2008; 51:216-226.
19. Menezes HS, Barra M, Bello AR, Martins CB, Zielinsky P. Fetal myocardial hypertrophy in an experimental model of gestational diabetes. Cardiol Young 2001; 11:609-613.
20. Caluwaerts S, Holemans K, van Bree R, Verhaeghe J, Van Assche FA. Is low-dose streptozotocin in rats an adequate model for gestational diabetes mellitus? J Soc Gynecol Investig 2003; 10:216-221.
21. Yamashita H, Shao J, Ishizuka T, et al. Leptin administration prevents spontaneous gestational diabetes in heterozygous Lepr(db/+) mice: effects on placental leptin and fetal growth. Endocrinology 2001; 142:2888-2897.
22. Mehta A, Hussain K. Transient hyperinsulinism associated with macrosomia, hypertrophic obstructive cardiomyopathy, hepatomegaly, and nephromegaly. Arch Dis Child 2003; 88:822-824.
23. Prasadan K, Daume E, Preuett B, et al. Glucagon is required for early insulin-positive differentiation in the developing mouse pancreas. Diabetes 2002; 51:3229-3236.
24. Dohrmann C, Gruss P, Lemaire L. Pax genes and the differentiation of hormone-producing endocrine cells in the pancreas. Mech Dev 2000; 92:47-54.
25. Holemans K, Caluwaerts S, Poston L, Van Assche FA. Diet-induced obesity in the rat: a model for gestational diabetes mellitus. Am J Obstet Gynecol 2004; 190:858-865.